MAHWAH, NJ, Aug. 18 /PRNewswire-Asia/ -- Mindray DS USA, a Mindray Global Company, announces the launch of the company's new premium M7 ultrasound system in the United States. The M7 platform is based on breakthrough System On Chip (SOC) technology, bringing a new level of imaging performance to a compact portable system.
"The new M7 platform brings high-end imaging capabilities to an ergonomically designed portable system," said Michael Thompson, vice president of Sales and Marketing, Mindray U.S. "This segment of the ultrasound market is experiencing significant growth as more healthcare facilities are requiring premium performance in a compact form. We believe this, coupled with the superb economical value, will support substantial demand for the M7 platform."
The M7 platform provides a wealth of advanced imaging features. These include octal-beam imaging technology which provides excellent temporal resolution along with an innovative implementation of multiple tissue harmonic imaging technologies to improve image quality for technically difficult patients. iZoom(TM) enables the user to view images from a longer distance by increasing the size of the clinical image display area on the screen and iTouch(TM) provides a single button image optimization. Tissue Doppler Imaging (TDI), Cine Compare, and real-time 3D are part of the platform as well. The system has an on-board workstation for patient information management plus the ability to transmit information wirelessly for a wide range of applications.
The M7 system recently received a 2010 "best of the best" award from red dot for product design. With more than 12,000 submissions from more than 60 countries, the international "red dot design award" is the largest and most renowned design competition in the world. The award-winning products are put before an international public in the red dot design museum.
In addition to launching the M7 platform, Mindray recently introduced a significant new upgrade for its M5 system. The new 3.0 release features full DICOM capability, networking, work list, MPPS, query and retrieve and structured reporting. Automatic measurement of the carotid's intima-media thickness (IMT) and wireless data transfer are included (regulatory clearance pending for IMT and wireless). Three new transducers -- curved, linear and cardiology -- are also options in the new upgrade.
"Part of Mindray's commitment to supporting excellence in patient care is providing an ongoing stream of upgrades to our clinicians," said Thompson. "This significant new upgrade to the M5 system is another example of offering our customers continuous, state-of-the-art imaging, resulting in greater diagnostic confidence."
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global operational headquarters in Shenzhen, China, and multiple sales offices in major domestic and international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com .
For investor and media inquiries, please contact: In the U.S.: Bryan Armstrong FD Tel: +1-312-553-6707 Email: firstname.lastname@example.org John Capodanno FD Tel: +1-212-850-5705 Email: email@example.com
|SOURCE Mindray Medical International Limited; Mindray DS USA|
Copyright©2010 PR Newswire.
All rights reserved